BiomX Inc.
8-K March 27, 2026
Key Highlights
- Developing innovative phage therapies for cystic fibrosis and chronic sinus issu...
- Active clinical research pipeline including the BX004 program
- Potential for future value creation through strategic partnerships or buyouts
Read Analysis
🤖 AI Generated